Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination...

por Hauswald, H., Jensen, A.D., Krauss, J., Haselmann, R., Lossner, K., Hartmann, S., Windemuth-Kieselbach, C., Münter, M.W., Debus, J.
Publicado 2018

Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: the NEAR protocol (NCT00115518)

por Jensen, AD, Münter, MW, Bischoff, H, Haselmann, R, Timke, C, Krempien, R, Sterzing, F, Nill, S, Heeger, S, Hoess, A, Haberkorn, U, Huber, PE, Steins, M, Thomas, M, Debus, J, Herfarth, KK
Publicado 2006

Salivary gland cancer: ESMO–European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up

por van Herpen, C., Vander Poorten, V., Skalova, A., Terhaard, C., Maroldi, R., van Engen, A., Baujat, B., Locati, L.D., Jensen, A.D., Smeele, L., Hardillo, J., Martineau, V. Costes, Trama, A., Kinloch, E., Even, C., Machiels, J.-P.
Publicado 2022